EDN
The headline loss is doing a little too much
Edenor’s latest Q2 2026 results look uglier at first glance than they really are. Headline net earnings fell, but that was mostly because last year had a one-off gain hanging around like a lucky parking ticket you can’t expect twice.
Underneath the accounting noise, the operating picture was sturdier: revenue rose 10% year over year and EBITDA jumped 94% year over year, excluding CAMMESA effects. Translation: the business is actually recovering, even if the bottom line decided to make drama its entire personality.
The real catalyst: Metrogas
The bigger investor story is Edenor’s reported $780 million bid for Metrogas. If approved, the deal would push Edenor beyond its current lane and into a more diversified operating profile — which is the kind of move that can re-rate a stock if the market starts believing in a longer growth runway.
But, and this is a fairly large but, deals like this come with all the usual baggage:
- regulatory approval risk
- integration headaches
- execution risk if the synergy slide deck turns out to be more optimistic than reality
Why you should care
The market may already be giving Edenor credit for its current operational improvement, which is why the stock can still look like it’s stuck in neutral even as the business gets better. That means the Metrogas bid is the kind of thing that could matter more than the quarterly earnings optics.
If the deal advances, investors may start treating Edenor less like a simple utility recovery play and more like a company trying to build a bigger regional platform. Big picture: the earnings miss may be noise, but the acquisition bid could be the plot twist.